Shanghai Easy-Flow Medical Tech Co., Ltd. ("Easy-Flow™") has officially announced that the EF-Control™ Mechanical Thrombectomy Kit, developed by Control Medical Technology, USA, has received approval from the National Medical Products Administration (NMPA) for commercial use in China. The device is designed to effectively remove thrombus from peripheral blood vessels with enhanced ease and efficiency.

The EF-Control™ Mechanical Thrombectomy Kit eliminates the need for external vacuum systems, streamlining the setup process and reducing procedural complexity. Its innovative one-handed aspirator design allows clinicians to perform thrombectomy procedures with greater ease. A dual one-way valve system maintains continuous negative pressure throughout the aspiration process, optimizing clot removal efficiency while effectively preventing blood reflux. This ensures greater control, minimized blood loss, and improved patient safety.

Designed with an all-spring-wound catheter structure, the EF-Control™ system delivers exceptional circumferential strength, preventing catheter clogging even when aspirating high-burden clots. Additionally, the catheter's enhanced flexibility allows for smooth navigation through tortuous vessels, ensuring a more stable and efficient procedure.

The EF-Control™ system has already been widely adopted and demonstrated its effectiveness in treating arterial and venous thrombosis across various thrombectomy scenarios. Its versatile design enables clinicians to tailor treatment approaches to individual patient needs, making it a valuable addition to the field of peripheral vascular intervention.

"We are excited to introduce this innovative solution to the Chinese market," said Zhenghua Miao, Chairman and General Manager of Easy-Flow™. "With the rapid growth of the peripheral thrombectomy market in China, the unique design of the EF-Control™ system will provide clinicians with expanded treatment options and greater procedural flexibility, ultimately improving patient outcomes."